The global DNA sequencing market is expected to reach USD 12.55 Billion in 2028 and register a revenue CAGR of 11.3% over the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth include increased funding by public and private sectors, growing healthcare spending, and government initiatives to support large-scale sequencing.
DNA sequencing is a laboratory technique used for determining nucleic acid sequence in a DNA molecule. DNA sequence information helps scientists and researchers to investigate the functions of genes and detect abnormalities. With rapid advancements in sequencing technology, DNA sequencing has become less expensive and can be carried out faster. Factors such as favorable government initiatives, high usage of DNA sequencing in biomarker discovery, clinical investigations, forensics, agrigenomics, and drug development, and increasing research on cancer and cancer treatment are driving market revenue growth.
In addition, improving healthcare infrastructure and research facilities, high demand for easy and fast clinical diagnosis, and increasing focus on developing portable sequencing technologies are expected to fuel growth of the global market. However, factors such as lack of trained professionals to operate advanced instruments and analyze genomic data, high capital investments, and fluctuating prices of reagents are expected to hamper global market growth to a certain extent during the forecast period. Apart from these, lack of funds for research and drug development in some developing countries and ethical issues associated with acquiring DNA sequences are expected to hamper overall market growth.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/3705
Some Key Highlights from the Report:
- Among product and services, the consumables segment is expected to account for significantly larger revenue share between 2021 and 2028. Increasing demand for ready-to-use consumables, availability of advanced kits and reagents, and a rising number of next-generation sequencing procedures are driving revenue growth of this segment.
- Based on end-use, pharmaceutical and biotechnology companies segment is expected to register highest revenue CAGR over the forecast period. This can be attributed to factors such as increasing patient pool, rising number of pharmaceutical and biotechnology companies across the globe, high demand for personalized medicine, low cost of sequencing, and increasing focus on developing enhanced products.
- North America is expected to account for largest revenue share over the forecast period owing to increasing prevalence of cancer, rising focus on drug development, and increased application of DNA sequencing in diagnostic, genomic research, agrigenomics & forensics, and oncology. Further, growing investments in research projects and increased funding by various public and private organizations are expected to fuel market growth in North America.
- Market revenue in Asia-Pacific is expected to expand at the fastest CAGR during the forecast period. Growth of the Asia-Pacific market can be attributed to high prevalence of cancer, improving healthcare infrastructure, growing healthcare expenditure, rising investments in drug discovery and R&D activities, and high usage of DNA sequencing technologies in applications such as genomics and clinical research, agriculture, and forensics, and increased funding by various public and private organizations.
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The DNA Sequencing market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.
Leading companies operating in the market are:
23andMe, Oxford Nanopore Technologies Ltd., Precise.ly, 54Gene, Guardant Health, Allogene Therapeutics, Pacific Biosciences, CardioDx, Helix, Human Longevity, Foundation Medicine, Freenome, Veritas Genetics, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Pacific Biosciences of California, Inc., QIAGEN, F. Hoffmann-La Roche Ltd.; Macrogen, Inc., Perkin Elmer, Inc., BGI, Bio-Rad Laboratories, Inc., Myriad Genetics, PierianDx, Eurofins Scientific, and Intrexon Bioinformatics Germany GmbH
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/3705
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
DNA Sequencing Market Segmentation:
Product & Services Outlook:
- Consumables
- Instruments
- Services
Technology Outlook:
- Sanger Sequencing
- Next Generation Sequencing
- Whole Genome Sequencing (WGS)
- Whole Exome Sequencing (WES)
- Targeted Sequencing & Resequencing
- Third Generation DNA Sequencing
- Single-Molecule Real-Time Sequencing (SMRT)
- Nanopore Sequencing
Application Outlook:
- Oncology
- Reproductive Health
- Clinical Investigation
- Agrigenomics & Forensics
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Consumer Genomics
- Others
End-Use Outlook:
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Geographic Segment Covered in the Report:
The DNA Sequencing report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
• North America (the USA and Canada)
• Europe (UK, Germany, France, and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• the Middle East and Africa (GCC and the rest of the Middle East and Africa)
Browse Full Report Description with Research Methodology, Table of Content, and Infographics @ https://www.reportsanddata.com/report-detail/dna-sequencing-market
Key market aspects are illuminated in the report:
- Executive Summary: It covers a summary of the most vital studies, the Global DNA Sequencing market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.
- Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global DNA Sequencing market, the years measured, and the study points.
- Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.
- Manufacture by Region: This Global DNA Sequencing report offers data on imports and exports, sales, production and key companies in all studied regional markets.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3705
Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Explore More Industry Research by Reports and Data:
Tinnitus Management Market @ https://www.biospace.com/article/tinnitus-management-market-demand-analysis-by-2030-increasing-geriatric-population-is-a-major-factor-driving-industry-revenue-growth/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs